Exelixis | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Cytokinetics USD 938.22M 843.36M 2025-03
Eisai JPY 265.56B 25.7B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Exelixis USD 183.75M 33.62M 2025-04
Genmab DKK 1.62B 8.24B 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Sanofi 7.44B 646M 2024-12
Takeda JPY 385.11B 109.01B 2025-03
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Xencor USD 39.67M 1.2M 2025-03



Exelixis Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.